Hospital
Children's Hospital Colorado
Children's Hospital Colorado was paid $17.82M by Medicaid between Jul 2019 and Dec 2024, across 66 billing codes. Its largest line is 99283, emergency room visit (moderate) — 49% of everything it billed.
33Billing provider infoCHILDREN'S HOSPITAL COLORADO
COLORADO SPRINGS, CO 80920
COLORADO SPRINGS, CO 80920
33aNPI1336637438assigned 04/25/2018
33bProvider typeChildren's Hospital
28Total paid$17.82M
24GClaims99,403
24DCodes billed66
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers
Next to other Children's Hospital providers in Colorado
Rank by total paid#1 of 13
Median peer was paid$304K
This provider vs. median59×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MICHAEL, LINDA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 5,068 | $620K | |
| 2020 | 11,867 | $905K | |
| 2021 | 14,590 | $1.67M | |
| 2022 | 24,281 | $4.72M | |
| 2023 | 24,478 | $5.51M | |
| 2024incomplete | 19,119 | $4.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 49% | 31,227 | 29,886 | $8.75M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 17% | 11,477 | 11,016 | $3.08M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 15% | 988 | 963 | $2.65M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.4% | 4,517 | 4,336 | $1.14M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.0% | 2,319 | 2,157 | $536K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 2.1% | 304 | 292 | $368K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.0% | 2,376 | 2,301 | $362K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.1% | 136 | 132 | $196K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 117 | 113 | $126K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,345 | 3,241 | $120K |
| 42830 | <1% | 24 | 24 | $67K | |
| G0378 | Hospital observation service, per hour | <1% | 73 | 67 | $61K |
54 more codes
| 95819 | <1% | 163 | $52K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,743 | $49K |
| 54161 | <1% | 12 | $34K | |
| 95782 | <1% | 24 | $30K | |
| 80053 | Comprehensive metabolic panel | <1% | 933 | $22K |
| J3490 | Unclassified drugs | <1% | 10,129 | $21K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 93 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 136 | $15K |
| 99285 | Emergency room visit (most serious) | <1% | 153 | $11K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 17 | $11K |
| 91300 | <1% | 717 | $10K | |
| 0002A | <1% | 393 | $10K | |
| 87631 | <1% | 81 | $9K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 44 | $9K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,220 | $8K |
| 0001A | <1% | 242 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,957 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 81 | $5K |
| 95715 | <1% | 12 | $5K | |
| 81001 | <1% | 915 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,551 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 53 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 107 | $4K |
| 95700 | <1% | 12 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 188 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 44 | $3K |
| J2704 | Injection, propofol, 10 mg | <1% | 3,139 | $2K |
| 91307 | <1% | 130 | $2K | |
| 74240 | <1% | 12 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 669 | $2K |
| 0071A | <1% | 84 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,127 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 30 | $1K |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 1,238 | $1K |
| 0072A | <1% | 46 | $1K | |
| 90656 | <1% | 30 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 209 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 384 | $781.46 |
| 86140 | <1% | 134 | $743.23 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $576.24 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 88 | $544.19 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 437 | $323.67 |
| 85046 | <1% | 39 | $270.61 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $223.36 |
| 82728 | <1% | 17 | $159.52 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 38 | $139.46 |
| 83690 | <1% | 28 | $98.48 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,909 | $79.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 136 | $66.02 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 37 | $50.68 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 214 | $26.72 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 145 | $11.75 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 24 | $8.58 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 92 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMICHAEL, LINDA (VP, CHIEF COMPLIANCE OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.